|
|
|
Vol. 12, No. 5, pp. 745-754, March 1, 1998
subunit of Escherichia coli RNA
polymerase into a transcriptional activator or an
activation target
Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts 02115 USA
| |
Abstract |
|---|
|
|
|---|
Evidence obtained in both eukaryotes and prokaryotes indicates
that arbitrary contacts between DNA-bound proteins and components of
the transcriptional machinery can activate transcription. Here we
demonstrate that the Escherichia coli
protein, which
copurifies with RNA polymerase, can function as a transcriptional
activator when linked covalently to a DNA-binding protein. We show
further that
can function as an activation target when this
covalent linkage is replaced by a pair of interacting polypeptides
fused to the DNA-binding protein and to
, respectively. Our findings imply that the
protein is associated with RNA polymerase holoenzyme in vivo, and provide support for the hypothesis that contact between a
DNA-bound protein and any component of E. coli RNA polymerase can activate transcription.
[Key Words:
subunit; E. coli; RNA
polymerase; transcriptional activator]
| |
Introduction |
|---|
|
|
|---|
Recent findings in both eukaryotes and
prokaryotes indicate that arbitrary protein-protein contacts can
trigger gene activation provided one of the protein partners is
tethered to the DNA and the other is a component (or is tethered to a
component) of RNA polymerase (RNAP) (Barberis et al. 1995
; Chatterjee
and Struhl 1995
; Klages and Strubin 1995
; Xiao et al. 1995
; Apone et
al. 1996
; Farrell et al. 1996
; Dove et al. 1997
; Gaudreau et al. 1997
; Gonzalez-Couto et al. 1997
; Lee and Struhl 1997
; for review, see Ptashne and Gann 1997
). Experiments in yeast have shown further that
direct fusion of a DNA-binding domain to a component of the RNAP II
holoenzyme can activate transcription from a promoter bearing a
recognition site for the DNA-binding domain (Barberis et al. 1995
;
Farrell et al. 1996
; Gaudreau et al. 1997
; for review, see Ptashne and
Gann 1997
), but analogous experiments have not been performed
previously in bacteria.
RNAP in Escherichia coli consists of an enzymatic core
composed of subunits
,
, and 
in the stoichiometry
2

, and one of several alternative
factors that confer on the enzyme the ability to recognize specific
promoters (Burgess 1976
; Hellman and Chamberlin 1988
). An additional
protein, omega (
), has been called a subunit of RNAP on the basis
of its copurification with RNAP core and holoenzyme in near
stoichiometric amounts (Burgess 1969
). The function of
is unknown
and, unlike the other subunits,
is not required for transcription
either in vitro (Heil and Zillig 1970
) or in vivo (Gentry and Burgess
1989
; Gentry et al. 1991
). Cells deleted for the gene encoding
(rpoZ) have no discernible mutant phenotypes (Gentry and
Burgess 1989
; Gentry et al. 1991
).
Many natural activators in bacteria bind the DNA near the promoters
they regulate and interact directly with one or more subunits of RNAP
(Busby and Ebright 1994
). The best known target of these interactions
is the
subunit of RNAP (Ishihama 1992
; Russo and Silhavy 1992
;
Ebright and Busby 1995
; Niu et al. 1996
). Some activators, however,
interact with the
subunit (Hochschild 1994
; Kuldell and
Hochschild 1994
; Li et al. 1994
; Artsimovitch et al. 1996
; Gerber and
Hinton 1996
), and evidence suggests that the
subunit may also
serve as an activation target in at least one case (Lee and Hoover
1995
). Finally the 
subunit has been identified as the target
of action of an activator that functions without binding to the DNA
(Miller et al. 1997
). In contrast, the
subunit has not been
implicated in activation to date.
In a previous study we fused a heterologous protein domain to the
subunit of E. coli RNAP and demonstrated that interaction between a DNA-bound protein and the heterologous protein domain tethered to
activated transcription from a test promoter (Dove et
al. 1997
). The magnitude of the activation correlated with the strength
of the protein-protein interaction, the interaction presumably
functioning to stabilize the binding of RNAP to the promoter. These
findings suggest that contact between a DNA-bound protein and any
subunit of RNAP could, in principle, activate transcription.
Here we show that covalent linkage of a DNA-binding protein to the
subunit can activate transcription from a test promoter bearing a
recognition site for the DNA-binding domain, and further that this
covalent linkage can be replaced by a protein-protein bridge. These
results support the hypothesis that any subunit of RNAP can serve as an
activation target, and provide evidence that the
protein is
associated with RNAP holoenzyme in vivo and that it is accessible at
the surface of the enzyme complex.
| |
Results |
|---|
|
|
|---|
The
subunit can activate transcription from a
test promoter when fused to a DNA-binding protein
To determine whether the
subunit of RNAP can mediate
transcriptional activation when tethered to the DNA upstream of a
promoter, we fused the
protein to the repressor (cI) protein of
bacteriophage
(see Fig. 1B). The
cI protein is a two-domain protein that binds DNA as a
dimer; the amino-terminal domain (NTD) is the DNA-binding domain,
whereas the carboxy-terminal domain (CTD) mediates dimer formation (and
higher order oligomerization) (Sauer et al. 1990
).
|
We fused the entire
protein (residues 1-90) to the carboxyl
terminus of the
cI protein through a small alanine linker
(see Materials and Methods). We placed the gene encoding this fusion protein downstream of an inducible promoter on a plasmid vector, thus
generating plasmid pBRcI-
. We introduced pBRcI-
into strain KS1
Z, which harbors on its chromosome a lac promoter
derivative (termed placOR2-62) bearing a single
operator centered 62 bp upstream of the transcription start
point. Note that
cI, which activates transcription from
the
PRM promoter when bound at a site centered at
position
42, cannot activate transcription
from placOR2-62 (Dove et al. 1997
) because the
operator is positioned too far from the promoter. In addition,
KS1
Z bears a deletion of the chromosomal locus encoding the
subunit. Unlike
cI, the
cI-
fusion
protein stimulated transcription ~70-fold, as measured by
-galactosidase assay (Fig. 2A). Primer extension
analysis confirmed that the fusion protein stimulated the production of correctly initiated transcripts (Fig. 2B). A similar experiment performed with strain KS1 revealed that the
cI-
fusion protein was unable to stimulate transcription from
placOR2-62 in the presence of endogenous
protein encoded by the chromosomal rpoZ gene (Fig. 2A).
|
Transcriptional activation by the
cI-
fusion protein is dependent
on its ability to bind DNA
To demonstrate that the stimulation of transcription from
placOR2-62 in KS1
Z by
cI-
depends on the ability of the fusion protein to bind to the
operator of placOR2-62, we introduced a single amino
acid substitution (S45A) into the
cI moiety of the fusion
protein that results in a severe reduction in operator binding
(Hochschild and Ptashne 1986
). This mutant version of the
cI-
fusion protein failed to stimulate
transcription from placOR2-62 (Fig. 2A).
We confirmed that the
cI(S45A)-
fusion protein is
specifically defective for operator binding by measuring its binding to a consensus
operator using an in vivo repression assay (data not
shown). Western blot analysis confirmed that the
cI-
and the
cI (S45A)-
fusion
proteins were present in the cell in comparable amounts (data not shown).
Interaction between a DNA-bound domain of Gal4 and a domain of
Gal11P fused to either the
or
subunit of RNAP results in transcriptional activation from a test
promoter
We then replaced the covalent interaction between the
cI protein and the
subunit of RNAP with a
protein-protein contact. For this purpose we took advantage of a pair
of protein domains originally shown to interact in yeast cells.
Transcriptional activation in yeast can be triggered by an apparently
fortuitous interaction between the dimerization region of the yeast
transcriptional activator Gal4 and a mutant form of the Gal11 protein
(Himmelfarb et al. 1990
; Barberis et al. 1995
), which despite its name,
is a component of the RNAP II holoenzyme and is required for full
transcription of many genes (Kim et al. 1994
; Barberis et al. 1995
;
Hengartner et al. 1995
). Ordinarily, in yeast, the dimerization region
of Gal4 does not mediate transcriptional activation when connected to
its own or another DNA-binding domain. However, in the presence of a
Gal11 mutant (called Gal11P for potentiator) bearing a single
amino acid substitution at position 342, the Gal4 dimerization region
functions as a powerful activating region; this activation results from
a specific interaction between the Gal4 dimerization region and the
portion of Gal11P bearing the amino acid substitution
(Barberis et al. 1995
; Farrell et al. 1996
).
To establish that this protein-protein interaction can also trigger
gene activation in E. coli, we first tested the abilities of
the relevant portions of Gal11P and Gal4 (Farrell et al.
1996
) to mediate transcriptional activation when fused to the
subunit of RNAP and to the
cI protein, respectively. To
do this, we proceeded as we had done previously (Dove et al. 1997
),
taking advantage of the domain structure of
, which initiates the
assembly of RNAP by forming a dimer. The
-NTD is responsible for
the assembly reaction (Hayward et al. 1991
; Igarashi et al. 1991
), and
the
-CTD, which is connected to the
-NTD by a flexible linker
region (Blatter et al. 1994
; Jeon et al. 1997
), can bind DNA (Ross et
al. 1993
; Blatter et al. 1994
) and is the natural target for many
transcriptional activators (Ishihama 1992
; Ebright and Busby 1995
). We
reasoned that if we replaced the
-CTD with an appropriate domain
of Gal11P, the resulting
-Gal11P chimera
would display a target that could be contacted by an appropriately
positioned
cI-Gal4 dimer (Fig. 3).
Therefore, we created two chimeric genes, one encoding the
-NTD
and linker connected to residues 263-352 of Gal11P, and the
other encoding full-length
cI (residues 1-236) connected to the dimerization region of Gal4 (residues 58-97) (see Materials and
Methods). We then tested the ability of the
cI-Gal4
fusion protein to activate transcription from
placOR2-62 in cells containing the
-Gal11P fusion protein (as well as wild type
encoded by the chromosomal rpoA gene). Figure 4A shows that
the
cI-Gal4 fusion protein activated transcription
~45-fold in KS1 cells containing the
-Gal11P fusion
protein but not in control cells containing an otherwise identical
fusion protein bearing the wild type form of Gal11. Primer extension analysis confirmed that the fusion protein stimulated the production of correctly initiated transcripts (Fig. 4B). We also
found that a different
cI-Gal4 fusion protein comprising only the NTD and linker region of
cI (residues 1-132)
fused to Gal4(58-97) activated transcription in KS1 cells harboring
the
-Gal11P fusion protein by a factor of approximately
eight (data not shown).
|
|
We reasoned that if we fused the appropriate domain of Gal11P
to the
subunit of RNAP the resulting
-Gal11P
chimera would, like the
-Gal11P chimera, display a
target that could be contacted by an appropriately positioned
cI-Gal4 dimer (Fig. 5A). Therefore, we
constructed a chimeric gene encoding the
subunit connected to
residues 263-352 of Gal11P (see Materials and Methods).
Figure 5B shows that the
cI-Gal4 fusion protein
(comprising residues 1-236 of
cI fused to residues 58-97 of Gal4) activated transcription ~20-fold in KS1
Z cells containing the
-Gal11P fusion protein, but not in
control cells containing the
-Gal11WT fusion protein.
Primer extension analysis confirmed that the fusion protein stimulated
the production of correctly initiated transcripts (Fig. 5C). In
contrast to the
cI-
fusion protein, the
cI-Gal4 fusion protein activated transcription in KS1
cells containing both wild-type
and the
-Gal11P
chimera (data not shown), indicating that in this case endogenous
does not compete effectively with the
-Gal11P chimera
for binding to RNAP (see Discussion).
|
| |
Discussion |
|---|
|
|
|---|
Transcriptional activation in E. coli by tethering a subunit of RNAP to DNA
We have demonstrated that covalent linkage of a DNA-binding
protein (
cI) to a component of RNAP (
) results in
transcriptional activation from a promoter bearing a recognition site
for the DNA-binding protein (a
operator). This form of activation
resembles the natural activation that occurs when the RNAP
subunit interacts with a DNA sequence element termed the UP element
that is found upstream of the
35 hexamer of rRNA promoters (as well
as some other promoters) (Ross et al. 1993
; Gaal et al. 1996
). As
mentioned above, the
subunit has two domains, and its CTD is a
sequence-specific DNA-binding domain (Blatter et al. 1994
; Gaal et al.
1996
). The interaction of the
-CTD with naturally occurring UP
elements has been reported to increase transcription by as much as
30-fold, and this increase reflects an increase in the initial binding of RNAP to the promoter and possibly a subsequent step in the initiation process (Ross et al. 1993
; Rao et al. 1994
).
Experiments performed in eukaryotic cells have also shown that
transcription can be activated by the direct fusion of DNA-binding domains to various components of the transcriptional machinery. For
example, fusion of the E. coli LexA repressor, a
sequence-specific DNA-binding protein, to the wild-type Gal11 protein
creates a powerful transcriptional activator in yeast that works on
promoters bearing LexA-binding sites, and this activation depends on
the portion of Gal11 that mediates its association with the RNAP II holoenzyme (Himmelfarb et al. 1990
; Barberis et al. 1995
; see also
Farrell et al. 1996
; Gaudreau et al. 1997
). Similarly, direct or
indirect fusion of a DNA-binding domain to the yeast TATA-binding protein (TBP) creates a transcriptional activator that works on promoters bearing a recognition site for the DNA-binding domain upstream of the TATA element, and this activation depends on the ability of TBP to interact with the TATA element (Chatterjee and Struhl
1995
; Klages and Strubin 1995
; Xiao et al. 1995
). Thus, recruitment of
the polymerase II holoenzyme and TBP to promoters in yeast cells, as
well as RNAP holoenzyme to bacterial promoters can be a rate-limiting
step in transcription initiation in vivo.
Transcriptional activation by arbitrary protein-protein interactions
In a previous study we showed that contact between a DNA-bound
protein and a heterologous protein domain fused to the
-NTD can
activate transcription in E. coli (Dove et al. 1997
). We have now generalized this finding by showing that an interacting pair of
protein fragments that triggers gene activation in yeast also triggers
gene activation in E. coli when one of the pair is fused to a
DNA-binding protein and the other is fused either to the
-NTD or
to the
protein. Specifically, we fused the dimerization domain of
Gal4 to the
cI protein and the relevant fragment of the
Gal11P protein either to the
-NTD or to
and
demonstrated that the
cI-Gal4 fusion protein stimulated
transcription from an appropriately designed test promoter in cells
containing either the
-Gal11P or the
-Gal11P fusion protein. These findings provide support
for the hypothesis that contact between a DNA-bound protein and any
component of RNAP can activate transcription in E. coli (Fig.
6). In particular, they indicate that the
subunit is not unique in its ability to mediate the effects of
artificial activators.
|
We note that the
cI-Gal4 fusion protein stimulated
transcription more strongly with the
-Gal11P than with
the
-Gal11P fusion protein (45- vs. 20-fold). We do not
know the reason for this difference, but we speculate that it may
reflect a difference in the number of Gal11P moieties
displayed by the RNAP holoenzyme in the two cases. Whereas the
subunit is presumed to associate with RNAP as a monomer, the
subunit assembles as a dimer. Therefore, at least a fraction of the
polymerase molecules assembled in the presence of chromosomally encoded
wild-type
and an excess of the
-Gal11P fusion
protein should display two Gal11P moieties, each of which
might be able to interact with a Gal4 moiety displayed on the DNA-bound
cI dimer. It is also possible that the observed
difference in activities (45-fold for the
-Gal11P
fusion protein and 20-fold for the
-Gal11P fusion
protein) reflects a difference in the fraction of RNAP molecules in the
cell that contain the fusion protein. Further experiments will be
required to test these possibilities.
The
protein is a subunit of RNA polymerase in vivo
Our demonstration that the
-Gal11P fusion protein
can function as an activation target provides strong evidence that the
protein is associated with RNAP in growing cells. This
demonstration taken together with the finding that the
cI-
fusion protein is a powerful activator of
transcription indicates, moreover, that
is accessible at the
surface of RNAP. Therefore, our results raise the possibility that
might serve as a target for natural DNA-bound activators, as well.
In our experiments with the
cI-
fusion protein (in
which the amino terminus of
is fused to the carboxyl terminus of
cI), we observed transcriptional activation only in a
strain deleted for the chromosomal rpoZ gene (encoding
).
This suggests first that the
cI-
fusion protein
associates with the same surface of RNAP as native
protein, and
second, that the native
protein associates preferentially. In
contrast, the
-Gal11P fusion protein (in which the
amino terminus of
is free) mediated transcriptional activation by
the
cI-Gal4 fusion protein in both the absence and
presence of chromosomally encoded
protein. This suggests that
this fusion protein competes effectively with native
protein for
association with RNAP. We suggest a possible explanation: The
amino-terminal portion of the
protein mediates its association with RNAP with the consequence that fusion of another protein at the
amino terminus weakens the association.
In vitro cross-linking experiments have suggested that
binds to
the 
subunit of RNAP (Gentry and Burgess 1993
). The
biological activity of our
cI-
fusion protein
should permit genetic identification of not only the residues on
that mediate its association with RNAP, but the interacting residues on

(or any other subunit of RNAP) as well.
Practical implications for prokaryotic two-hybrid and one-hybrid systems
Our previous demonstration that contact between a DNA-bound
protein and a protein domain fused to the
subunit of RNAP can activate transcription suggested the possibility of establishing a
transcription-based two-hybrid assay for detecting protein-protein interactions in E. coli (Dove et al. 1997
). Here we have
demonstrated the feasibility of this approach by showing that two
polypeptides known to interact in yeast and in vitro (Farrell et al.
1996
) can activate transcription in E. coli when one of the
pair is fused to a subunit of RNAP (either
or
) and the
other is fused to a DNA-binding protein (
cI).
Previous studies have demonstrated that heterologous protein domains
that mediate dimer formation can functionally substitute for the
cI-CTD when fused to the
cI-NTD,
resulting in biologically active fusion proteins that bind efficiently
to
operators (for review, see Hu 1995
). In designing the
cI-Gal4 fusion protein, we sought to compare the effects
of fusing the Gal4 moiety to the end of the
cI linker (at
residue 132) and to the end of full-length
cI (at residue
236). Although both of the resulting fusion proteins bound to
operators and stimulated transcription in the presence of the
-Gal11P fusion protein (Fig. 4; data not shown), the
full-length
cI-Gal4 fusion protein was more active,
presumably because the
cI-CTD mediates more efficient
dimerization than the Gal4 moiety. The finding that a heterologous
protein domain can be fused to the carboxyl terminus of
cI without interfering with
cI-CTD-mediated dimerization implies that heterologous
protein domains can be tethered to the DNA through the
cI
protein regardless of whether or not they have the potential to dimerize.
The utility of this strategy was confirmed by our construction of a
biologically active
cI-
fusion protein. In turn,
the ability of this fusion protein to activate transcription from a
promoter bearing a
operator demonstrates the feasibility of establishing a so-called "one-hybrid" assay in E. coli
to detect specific protein-DNA interactions (Li and Herskowitz 1993
;
Wang and Reed 1993
; Inouye et al. 1994
).
Mechanistic implications
Together our findings with both the
and the
fusion
proteins suggest that depending on the nature of the promoter, contact between a DNA-bound protein and any accessible surface of RNAP can
activate transcription, presumably by stabilizing the binding of RNAP
to the promoter. We suspect, however, that this form of activation
would not work at all promoters. In particular, if the activity of a
given promoter is not limited by its ability to stably bind RNAP in
vivo (for example, see Morett and Buck 1989
; Hidalgo and Demple 1997
;
for reviews, see also Kustu et al. 1991
; Summers 1992
; Gralla 1996
;
Ptashne and Gann 1997
), then we hypothesize that the artificial
activators we have designed would be ineffective. In this regard, it
might be possible to use the
cI-
fusion protein as
a tool for classifying promoters in vivo.
| |
Materials and methods |
|---|
|
|
|---|
Media, growth conditions, and genetic techniques
Bacteria were cultured routinely in L broth or on L-agar plates
(Miller 1972
). Where needed, antibiotics were used at the following
concentrations: carbenicillin (50 µg/ml),
chloramphenicol (25 µg/ml), kanamycin (50 µg/ml), and tetracycline (20 µg/ml). Transductions were performed using
generalized transducing phage P1vir as described previously
(Sternberg and Maurer 1991
).
Bacterial strains
E. coli strain XL1-blue (Stratagene) was used routinely
as a cloning vehicle for plasmid constructions. The E. coli
strain KS1 has been described previously (Dove et al. 1997
) and harbors the artificial promoter derivative placOR2-62
consisting of the
operator OR2 centered 62 bp upstream
of the transcriptional start site of the lac promoter. This
promoter and the linked lacZ gene are present on a
imm21 prophage. The E. coli strain KS1
Z was
created by P1-mediated transduction of the
spoS3::cat mutation (an
null allele) from
CF2790 (Xiao et al. 1991
) into recipient strain KS1.
DNA manipulation and oligonucleotides
Standard molecular biology techniques (Sambrook et al. 1989
) were
used for cloning, DNA purification, and analysis. The PCR was performed
using Expand (Boehringer Mannheim) and restriction enzymes were
obtained from New England Biolabs. DNA was sequenced by the dideoxy
method using Sequenase (U.S. Biochemical).
Oligonucleotides used to make the different plasmids were purchased
from Operon Technologies, Inc., and were as follows: OL.2 (5
-CAGTGATTCTGCATTCTGGCTTGAG-3
); OL.3
(5
-GCGGATCCTAGGTCAAAATAATCCTGTTAA-3
); OL.6
(5
-CAGACGTTTGGCGAATCAAGGCTAGAAAGACTGG-3
);
OL.7 (5
-TAGCCTTGATTCGCCAAACGTCTCTTCAGG-3
); OL.13
(5
-CTGCTGTTGAGGCTCTGGTTTCTCTTCTTTCAC-3
); OL.15
(5
-GAGAAACCAGAGCCTCAACAGCAGCAAATGCAACC-3
); OL.18
(5
-AGCGGATCCTCACAAAGCTTGGATTTTTCTCAGG-3
);
OL.R1 (5
-GTGCCGGTTCTACCC-3
); OL.32 (5
-TAGGATCCGGCGCGCCTAAGATCTTGCGGCCGCGCCAAACGTCTCTTCAGGCCACTG-3
); OL.39 (5
-ATATGCGGCCGCACGCGTAACTGTTCAGGACG-3
); OL.40
(5
-ATATGTCGACTTAACGACGACCTTCAGCAAT-3
); OL.41
(5
-AAAGTTCCATATGGCACGCGTAACTGTTCAGG-3
); OL.42
(5
-TATATGCGGCCGCACGACGACCTTCAGCAATAGCG-3
); OL.43
(5
-ATATGCGGCCGCACCTCAACAGCAGCAAATGCAACC-3
); OL.44
(5
-ATATGTCGACTCACAAAGCTTGGATTTTTCTCAGG-3
); OL.54 (5
-ATATATCATATGAGCACAAAAAAGAAACC-3
); OL.55
(5
-TTCTCTGGCGATTGAAGGGC-3
).
Plasmids
Plasmids used in this study are listed in Table 1. All inserts in plasmids that were generated by the PCR were subsequently sequenced to confirm that no errors had been introduced as a result of the PCR process.
|
Plasmid pLX20 is a derivative of pBR322 (Bolivar et al. 1977
), confers
ApR, and bears the cI gene under the control of the
lacUV5 promoter (F. Whipple, unpubl.).
Plasmid pBRcI-
is a derivative of pLX20, confers ApR,
and encodes residues 1-236 of
cI fused to two Ala
residues, which in turn are fused to residues 1-90 of the
subunit of E. coli RNAP. The expression of the
cI-
fusion protein is under the control of the
lacUV5 promoter. The primary sequence of the
cI-
fusion protein junction from
cI
residue 235 inclusive is PheGlyAlaAlaAlaArg, where the
underlined residues are the first and second, respectively, in the
primary sequence of
. Note that the initiating Met of
was
not included in the fusion protein, as it is not present in the mature
protein (Gentry and Burgess 1986
), and therefore, the Ala residue that
follows the initiating Met is classified here as residue one.
pBRcI-
was constructed by replacing the HindIII-SalI fragment from pLX20 with two fragments
of DNA. One fragment (comprising a segment of the cI gene) was
a HindIII-NotI-digested PCR product that was made
using primers OL.2 and OL.32 with pAC
cI as template. This
fragment contains a NotI site at the 3
end of
cI. The second fragment (comprising the
gene) was a
NotI-SalI-digested PCR product that was made using
primers OL.39 and OL.40 with pE
C-1 as template.
Plasmid pBRcI(S45A)-
is identical to pBRcI-
except that the
cI moiety of the fusion protein harbors the S45A
mutation. pBRcI(S45A)-
was constructed by replacing the
NdeI-NsiI fragment from pBRcI-
with an
NdeI-NsiI-digested PCR product that was made using
primers OL.54 and OL.55 with pLCF3 as template. pBR
cI is the same as
pLR1
cI (Whipple et al. 1994
).
Plasmid pACLGF2 is a derivative of pAC
cI, confers
CmlR, and encodes residues 1-236 of
cI fused
to residues 58-97 of Gal4 under the control of the lacUV5
promoter. pACLGF2 was made by replacing the
HindIII-BstYI fragment from pAC
cI with a
HindIII-BamHI digested PCR product made using
primers OL.2 and OL.3. The PCR product comprised a fragment of the
3
end of the cI gene fused directly to the coding
sequence of Gal4 (residues 58-97), and two PCR products (made using primers
OL.2 and OL.7 with pAC
cI as template and primers OL.6 and OL.3 with
pNS113 as template, respectively) served as template for its generation.
Plasmid pACTcLGF2 is a derivative of pACLGF2 that confers TcR
and like pACLGF2 encodes residues 1-236 of
cI fused to
residues 58-97 of Gal4 under the control of the lacUV5
promoter. pACTcLGF2 was made by replacing the
HindIII-EcoRI fragment from pAC
cI with the EcoRI-BstYI fragment from pBR322 (encoding the
TcR gene) and the appropriate
BstYI-HindIII fragment from pACLGF2.
Plasmid pBR
-Gal11WT is a derivative of pBR
,
confers ApR, and encodes residues 1-248 of the
subunit
of E. coli RNAP fused to residues 263-352 of wild-type Gal11
under the control of tandem lpp and lacUV5 promoters.
pBR
-Gal11WT was made by replacing the
EcoRI-BamHI fragment from pBR
with an
EcoRI-BamHI-digested PCR product made using primers
OL.R1 and OL.18. The PCR product comprised a fragment of the 3
end
of the cI gene fused directly to the coding sequence of Gal11
(residues 263-352), and two PCR products (made using primers OL.R1 and
OL.13 with pBR
as template and primers OL.15 and OL.18 with pSO23
as template, respectively) served as template for its generation. pBR
-Gal11P was similarly made using pSO32 instead of
pSO23 as template.
Plasmid pBR
-Gal11WT confers ApR and encodes
residues 1-90 of the
subunit of E. coli RNAP fused to
three Ala residues, which in turn are fused to residues 263-352 of
wild-type Gal11. The expression of the
-Gal11WT fusion
protein is under the control of the lacUV5 promoter.
pBR
-Gal11WT was made by replacing the
NdeI-SalI fragment from pLX20 with two fragments of
DNA. One fragment (comprising a segment of the
gene) was an
NdeI-NotI-digested PCR product that was made using primers OL.41 and OL.42 with pE3C-1 as template. This introduces an
NdeI site at the start and a NotI site at the 3
end of
. The second fragment (comprising the Gal11WT
coding sequence from residues 263-352) was a
NotI-SalI-digested PCR product that was made using
primers OL.43 and OL.44 with pSO23 as template.
pBR
-Gal11P was similarly made using pSO32 instead of
pSO23 as template.
-Galactosidase assays
SDS-CHCl3 permeabilized cells were assayed for
-galactosidase activity essentially as described (Miller 1972
).
Assays were performed at least three times in duplicate on separate
occasions, with similar results. Values are the averages from one
experiment and duplicate measurements differed by <10%.
Primer extension analysis
RNA isolation, primer labeling, primer extension assays, and
transcriptional start site identification were as described previously (Dove et al. 1997
).
| |
Acknowledgments |
|---|
We thank Mike Cashel, Luc Gaudreau, Dan Gentry, Keith Joung, Mark Ptashne, and Fred Whipple for plasmids and strains. We also thank Yan Ye Xia for excellent technical assistance. We are very grateful to Keith Joung for helpful discussions and thank Mark Ptashne, Gareth King, John Mekalanos, and Bill Forrester for comments on the manuscript. This work was supported by National Institutes of Health grant GM44025 (A.H.), by the National Science Foundation Presidential Young Investigator Award (A.H.), and by an established investigatorship from the American Heart Association (A.H.).
The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.
| |
Footnotes |
|---|
Received December 3, 1997; revised version accepted January 15, 1998.
1 Corresponding author.
E-MAIL ahochsch{at}warren.med.harvard.edu; FAX (617) 738-7664.
| |
References |
|---|
|
|
|---|
and
70 subunits of Escherichia coli RNA polymerase.
J. Biol. Chem.
271:
32343-32348
subunit: C-terminal 85 amino acids constitute a domain capable of dimerization and DNA binding.
Cell
78:
889-896[CrossRef][Medline].
subunit: Structure and function.
Curr. Opin. Genet. Dev.
5:
197-203[CrossRef][Medline].
subunit of RNA polymerase: Novel DNA-binding domain architecture.
Genes & Dev.
10:
16-26
) subunit of Escherichia coli RNA polymerase.
Gene
48:
33-40[CrossRef][Medline]. 
as the binding site of
.
Biochemistry
32:
11224-11227[CrossRef][Medline].
subunit of Escherichia coli RNA polymerase.
J. Mol. Biol.
221:
23-29[CrossRef][Medline].
repressor talks to RNA polymerase.
Curr. Biol.
4:
440-442[CrossRef][Medline].